A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
Eli Lilly and Company
Kivu Bioscience Inc.
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
National Cancer Institute (NCI)
MacroGenics
SystImmune Inc.
SN BioScience
Boundless Bio, Inc.
AbbVie
Janux Therapeutics
NiKang Therapeutics, Inc.
University of Virginia
Theratechnologies
BeiGene
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
AstraZeneca
Rhizen Pharmaceuticals SA
Xencor, Inc.
HiberCell, Inc.
MacroGenics
Syros Pharmaceuticals
AstraZeneca
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Gossamer Bio Inc.
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
AstraZeneca
Abramson Cancer Center at Penn Medicine
Celgene
PharmaMar
University of Wisconsin, Madison
AbbVie
Oncology Institute of Southern Switzerland
Pfizer
Merrimack Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Northwestern University
Santa Maria Biotherapeutics